Table 4.
Statistically non-significant results of Experiment II: Ostarine (OST), Raloxifen (RAL), Combination (OST + RAL)
| Groups | Non-ORX | ORX | OST-P | RAL-P | OST + RAL-P | ANOVA p value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample size | `10 | 9 | 9 | 9 | 8 | ||||||
| Parameters | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Weights | |||||||||||
| Body weight (beginning of trial) [g] | 631.5 | 22.7 | 624.9 | 35.0 | 637.9 | 23.4 | 640.4 | 29.3 | 631.5 | 20.2 | 0.539 |
| GM weight/BW [mg/g] | 4.90 | 0.60 | 4.57 | 1.42 | 4.44 | 1.07 | 5.03 | 1.55 | 5.05 | 0.99 | 0.585 |
| SM weight [g] | 0.29 | 0.03 | 0.27 | 0.03 | 0.29 | 0.04 | 0.27 | 0.05 | 0.24 | 0.07 | 0.055 |
| SM weight/BW [mg/g] | 0.42 | 0.05 | 0.39 | 0.13 | 0.40 | 0.11 | 0.48 | 0.09 | 0.44 | 0.12 | 0.216 |
| Muscle fibers | |||||||||||
| LM | |||||||||||
| STO + FTO | |||||||||||
| Area (µm2) | 1789 | 371 | 1627 | 366 | 1645 | 366 | 1778 | 450 | 1601 | 407 | 0.243 |
| Diameter (µm) | 47.3 | 4.9 | 45.0 | 4.9 | 45.3 | 5.0 | 46.9 | 6.0 | 44.7 | 5.2 | 0.236 |
| FTG | |||||||||||
| Area (µm2) | 5997 | 1584 | 5993 | 1427 | 5906 | 1416 | 6235 | 1411 | 5656 | 758 | 0.671 |
| Diameter (µm) | 86.4 | 11.5 | 86.5 | 10.1 | 85.8 | 9.9 | 88.2 | 10.2 | 84.4 | 5.7 | 0.735 |
| Capillary ratio | |||||||||||
| LM | 1.7 | 0.3 | 1.9 | 0.4 | 1.7 | 0.4 | 1.8 | 0.4 | 2.0 | 0.4 | 0.085 |
| Serum analysis (U/l) | |||||||||||
| Mg | 0.8 | 0.1 | 0.7 | 0.1 | 0.7 | 0.1 | 0.7 | 0.1 | 0.7 | 0.1 | 0.157 |
| CK | 5715 | 1844 | 5568 | 2657 | 5920 | 3310 | 6530 | 2722 | 7494 | 4675 | 0.509 |
SD dtandard deviation